Article Information
History
- February 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Nicholas Cheng1,2,
- Kimberly Skead1,2,
- Althaf Singhawansa4,5,6,
- Tom W. Ouellette1,2,
- Mitchell Elliott4,5,
- David W. Cescon4,5,6,
- Scott V. Bratman6,7,8,
- Daniel D. De Carvalho6,7,
- David Soave1,3 and
- Philip Awadalla1,2,9,10,*
- 1Computational Biology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
- 2Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
- 3Department of Mathematics, Wilfrid Laurier University, Waterloo, Ontario, Canada
- 4Department of Medicine, University of Toronto, Toronto, Ontario, Canada
- 5Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
- 6Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
- 7Department of Medical Biophysics, University of Toronto, Ontario, Canada
- 8Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
- 9Ontario Health Study, Ontario Institute for Cancer Research, Toronto, Canada
- 10Dalla Lana School of Public Health, University of Toronto, Ontario Canada
- ↵*Corresponding author: Philip Awadalla (Philip.awadalla{at}oicr.on.ca)
Posted February 01, 2023.
Pre-diagnosis plasma cell-free DNA methylome profiling up to seven years prior to clinical detection reveals early signatures of breast cancer
